Cargando…

Covid-19 in Parkinson's Disease treated by drugs or brain stimulation

PURPOSE: Covid-19 has affected all people, especially those with chronic diseases, including Parkinson's Disease (PD). Covid-19 may affect both motor and neuropsychiatric symptoms of PD patients. We intend to evaluate different aspects of Covid-19 impact on PD patients. METHODS: 647 PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salari, M., Etemadifar, M., Zali, A., Aminzade, Z., Navalpotro-Gomez, I., Tehrani Fateh, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Neurología. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326006/ https://www.ncbi.nlm.nih.gov/pubmed/34366530 http://dx.doi.org/10.1016/j.nrl.2021.07.002

Ejemplares similares

Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
por: Salari, Mehri, et al.
Publicado: (2022)

Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
por: Salari, Mehri, et al.
Publicado: (2021)

Case series: New‐onset freezing of gait in combined use of deep brain stimulation and Levodopa
por: Salari, Mehri, et al.
Publicado: (2021)

Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Deep brain stimulation of anteromedial globus pallidus internus improved OCD rather than tics in a Gilles de la Tourette syndrome patient
por: Aminzade, Zahra, et al.
Publicado: (2021)

Can COVID‐19 accelerate neurodegeneration?
por: Salari, Mehri, et al.
Publicado: (2021)

Atypical parkinsonism and self‐mutilation: A new lens on the old concept
por: Salari, Mehri, et al.
Publicado: (2021)

Atypical parkinsonism and self‐mutilation: A new lens on the old concept
por: Salari, Mehri, et al.
Publicado: (2021)

Serum leptin levels in Iranian patients with Parkinson's disease
por: Salari, Mehri, et al.
Publicado: (2018)

Atypical Parkinsonism: Methamphetamine may play a role
por: Salari, Mehri, et al.
Publicado: (2022)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Atypical parkinsonism can be a presenting feature of late‐onset Huntington's disease
por: Salari, Mehri, et al.
Publicado: (2022)

Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
por: Salari, Mehri, et al.
Publicado: (2022)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Fulminant encephalitis as a sole manifestation of COVID-19
por: Etemadifar, Masoud, et al.
Publicado: (2020)

Autoimmune meningoencephalitis associated with anti‐glutamic acid decarboxylase antibody following COVID‐19 infection: A case report
por: Salari, Mehri, et al.
Publicado: (2022)

Movement Disorders Associated with COVID-19
por: Salari, Mehri, et al.
Publicado: (2021)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Functional correlates of response inhibition in impulse control disorders in Parkinson’s disease
por: Esteban-Peñalba, Teresa, et al.
Publicado: (2021)

Impulsivity in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation—An exploratory study
por: Pham, U., et al.
Publicado: (2021)

Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease
por: Martín-Bastida, Antonio, et al.
Publicado: (2021)

WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
por: Etemadifar, M., et al.
Publicado: (2020)

Successful seroconversion following mild COVID-19 contraction in a double-vaccinated B-cell-depleted person with multiple sclerosis: A hint towards booster efficacy?
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic
por: Salari, Mehri, et al.
Publicado: (2020)

Demographic features and clinical characteristics of patients with Parkinson’s disease in Isfahan, Iran
por: Salari, Mehri, et al.
Publicado: (2018)

Long-Term Mortality Analysis in Parkinson's Disease Treated with Deep Brain Stimulation
por: Rocha, Sofia, et al.
Publicado: (2014)

Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease
por: Hickey, Patrick, et al.
Publicado: (2016)

Deep Brain Stimulation for Parkinson’s Disease During the COVID-19 Pandemic: Patient Perspective
por: Zhang, Chencheng, et al.
Publicado: (2021)

Adaptive deep brain stimulation in Parkinson's disease
por: Beudel, M., et al.
Publicado: (2016)

Deep Brain Stimulation in the Treatment of Parkinson’s Disease
por: Shah, Heeya, et al.
Publicado: (2022)

Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson’s disease, Isfahan, Iran
por: Salari, Mehri, et al.
Publicado: (2017)

Effects of COVID-19 lockdown on chronic drug-resistant pain patients treated using brain stimulation approaches
por: Brocalero-Camacho, Angela, et al.
Publicado: (2020)

Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2021)

Illness Representations and Coping Strategies in Patients Treated with Deep Brain Stimulation for Parkinson’s Disease
por: Baertschi, Marc, et al.
Publicado: (2020)

Deep brain stimulation in Parkinson’s disease
por: Mehanna, Raja, et al.
Publicado: (2013)

Deep Brain Stimulation in Parkinson's Disease
por: Mehanna, Raja, et al.
Publicado: (2018)

Deep brain stimulation for Parkinson's disease
por: Hariz, Marwan, et al.
Publicado: (2022)

Adaptive Deep Brain Stimulation In Advanced Parkinson Disease
por: Little, Simon, et al.
Publicado: (2013)

Post-COVID-19 acute disseminated encephalomyelitis: Case report and review of the literature
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease
por: Molina, Rene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_htvndhsiji81ejlqirquqij1kv